Pharmaceutical Executive podcast

Pharmaceutical Executive Daily: FDA Approves Three New Therapies

0:00
3:08
Rewind 15 seconds
Fast Forward 15 seconds
FDA approves three new therapies, a wave of dealmaking led by Johnson & Johnson, Eli Lilly, AmyriAD Therapeutics, and Sanofi, and Ossium Health’s Kevin Caldwell joins The Ron Lanton Report on rebuilding bone marrow transplants around deceased-donor marrow.

More episodes from "Pharmaceutical Executive"